These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21492077)

  • 1. Emerging therapeutic targets and agents for pancreatic cancer therapy--where are we and where we have to go?
    Sebens S; Kalthoff H
    Anticancer Agents Med Chem; 2011 Jun; 11(5):408-10. PubMed ID: 21492077
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies.
    Bahrami A; Khazaei M; Bagherieh F; Ghayour-Mobarhan M; Maftouh M; Hassanian SM; Avan A
    J Cell Physiol; 2017 Nov; 232(11):2931-2937. PubMed ID: 28083912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma.
    Zhen DB; Coveler A; Zanon S; Reni M; Chiorean EG
    Semin Oncol; 2018 Jun; 45(3):107-115. PubMed ID: 30391013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic targeting in pancreatic cancer.
    van Kampen JG; Marijnissen-van Zanten MA; Simmer F; van der Graaf WT; Ligtenberg MJ; Nagtegaal ID
    Cancer Treat Rev; 2014 Jun; 40(5):656-64. PubMed ID: 24433955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted drug delivery systems for pancreatic cancer.
    Khare V; Alam N; Saneja A; Dubey RD; Gupta PN
    J Biomed Nanotechnol; 2014 Dec; 10(12):3462-82. PubMed ID: 26000366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer.
    Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P
    Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology.
    Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY
    Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key role of pancreatic stellate cells in pancreatic cancer.
    Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV
    Cancer Lett; 2016 Oct; 381(1):194-200. PubMed ID: 26571462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropilin and neuropilin associated molecules as new molecular targets in pancreatic adenocarcinoma.
    Muders MH
    Anticancer Agents Med Chem; 2011 Jun; 11(5):442-7. PubMed ID: 21492075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pancreatic carcinoma].
    Okamoto T; Onda S
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():463-7. PubMed ID: 23513884
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecularly targeted therapies in metastatic pancreatic cancer: a systematic review.
    Zagouri F; Sergentanis TN; Chrysikos D; Zografos CG; Papadimitriou CA; Dimopoulos MA; Filipits M; Bartsch R
    Pancreas; 2013 Jul; 42(5):760-73. PubMed ID: 23774698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current adjuvant therapeutic approaches for pancreatic cancer.
    Ozmen F; Şahin TT; Ozmen MM
    Adv Ther; 2015 Jan; 32(1):42-56. PubMed ID: 25595483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing endoscopic ultrasound-guided fine needle aspiration in identifying molecular targets for pancreatic cancer.
    Ogbonna OH; Saif MW
    JOP; 2013 Jul; 14(4):316-7. PubMed ID: 23846916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine network: new targeted therapy for pancreatic cancer.
    Matsuo Y; Takeyama H; Guha S
    Curr Pharm Des; 2012; 18(17):2416-9. PubMed ID: 22372505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
    Tanaka S
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S197-205. PubMed ID: 25749932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer.
    Li Y; Sarkar FH
    Int J Biol Sci; 2016; 12(3):326-37. PubMed ID: 26929739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular target therapy for gastroenteropancreatic neuroendocrine tumors].
    Inoue N; Komoto I; Awane M; Imamura M
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():492-5. PubMed ID: 23513889
    [No Abstract]   [Full Text] [Related]  

  • 18. From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors.
    Wiedenmann B; Pavel M; Kos-Kudla B
    Neuroendocrinology; 2011; 94(3):177-90. PubMed ID: 21893937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target therapies in pancreatic carcinoma.
    Silvestris N; Gnoni A; Brunetti AE; Vincenti L; Santini D; Tonini G; Merchionne F; Maiello E; Lorusso V; Nardulli P; Azzariti A; Reni M
    Curr Med Chem; 2014; 21(8):948-65. PubMed ID: 23992319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors.
    Raj N; Reidy-Lagunes D
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):119-33. PubMed ID: 26614372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.